Sign in

CIK 0001799788

  • Non-accelerated filer
  • Smaller reporting company

Greenwich LifeSciences, Inc.

Sign in to watch
Ticker
GLSI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
205473709
Phone
+1 203-434-3290
Business address
3992 BLUEBONNET DR, BUILDING 14, STAFFORD, TX, 77477
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-12-24 Hallock Kenneth Director Grant or award · Stock Options +41,349 82,698
2022-06-22 Hallock Kenneth Director Grant or award · Stock Options +41,349 41,349
2022-01-21 Hallock Kenneth Director Purchase +300 $16.32 $5K 397,304
2020-11-24 Hallock Kenneth Director Purchase +1,000 $5.39 $5K 397,004
2020-11-20 Hallock Kenneth Director Purchase +1,000 $5.37 $5K 396,004
2020-09-29 Hallock Kenneth Director Purchase +8,333 $4.60 $38K 395,004
2020-09-29 Hallock Kenneth Director Option exercise +18,727 276,095
2020-09-29 Hallock Kenneth Director Option exercise +18,727 294,822
2020-09-29 Hallock Kenneth Director Option exercise +79,121 386,671
2020-09-29 Hallock Kenneth Director Option exercise · Series B Preferred Stock −18,727 0
2020-09-29 Hallock Kenneth Director Option exercise · Series C Preferred Stock −18,727 0
2020-09-29 Hallock Kenneth Director Option exercise · Series D Preferred Stock −79,121 0
2020-09-29 Hallock Kenneth Director Other acquisition · Series D Preferred Stock +12,728 12,728
2020-09-29 Hallock Kenneth Director Option exercise · Series D Preferred Stock −12,728 0
2020-09-29 Hallock Kenneth Director Purchase +74,782 $5.75 $430K 257,368

Page 1 of 1 · 15 trades